On April 27, 2015, the Board of Directors of Stemline Therapeutics, Inc. appointed Alan S. Forman to the Board. Mr. Forman will serve as a director until his term expires at the 2015 annual meeting of stockholders, at which time he will stand for election by the company's stockholders. Alan S. Forman is a Director of Investments at the Yale University Investments Office.
Stemline Therapeutics, Inc.
Equities
US85858C1071
Biotechnology & Medical Research
1st Jan change | Capi. | |
---|---|---|
+13.61% | 118B | |
+13.07% | 106B | |
-3.48% | 24.28B | |
+1.08% | 21.96B | |
-9.23% | 18.16B | |
-42.12% | 16.37B | |
-17.50% | 15.56B | |
+4.85% | 13.63B | |
+31.30% | 12.27B |